'Pharma Bro' firm reaches $40M settlement in gouging case
Headline from Quad-City Times
SACRAMENTO, Calif. (AP) — A company once owned by “Pharma Bro" Martin Shkreli will pay up to $40 million to settle allegations that it jacked up the price of a
Quad-City Times's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
SACRAMENTO, Calif. (AP) — A company once owned by “Pharma Bro" Martin Shkreli will pay up to $40 million to settle allegations that it jacked up the price of a
Vyera Pharmaceuticals, once owned by “Pharma Bro" Martin Shkreli, will pay $40 million to settle allegations it increased the price of a life-saving medication by 4,000%.
A company once owned by “Pharma Bro” Martin Shkreli will pay up to $40 million to settle allegations that it jacked up the price of a life-saving medication by roughly 4,000% after obtaining exclusive rights to the drug.
A drug company previously owned by "Pharma Bro" Martin Shkreli and its parent company have agreed to pay up to $40 million over allegations of price gouging.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
'Pharma Bro' firm reaches $40M settlement in gouging case | Since Then
